Regulation of immune responses and hematopoiesis by the Rap1 signal
- PMID: 17383543
- DOI: 10.1016/S0065-2776(06)93006-5
Regulation of immune responses and hematopoiesis by the Rap1 signal
Abstract
Rap1 (Ras-proximity 1), a member of the Ras family of small guanine triphosphatases (GTPases), is activated by diverse extracellular stimuli. While Rap1 has been discovered originally as a potential Ras antagonist, accumulating evidence indicates that Rap1 per se mediates unique signals and exerts biological functions distinctly different from Ras. Rap1 plays a dominant role in the control of cell-cell and cell-matrix interactions by regulating the function of integrins and other adhesion molecules in various cell types. Rap1 also regulates MAP kinase (MAPK) activity in a manner highly dependent on the context of cell types. Recent studies (including gene-targeting analysis) have uncovered that the Rap1 signal is integrated crucially and unpredictably in the diverse aspects of comprehensive biological systems. This review summarizes the role of the Rap1 signal in developments and functions of the immune and hematopoietic systems as well as in malignancy. Importantly, Rap1 activation is tightly regulated in tissue cells, and dysregulations of the Rap1 signal in specific tissues result in certain disorders, including myeloproliferative disorders and leukemia, platelet dysfunction with defective hemostasis, leukocyte adhesion-deficiency syndrome, lupus-like systemic autoimmune disease, and T cell anergy. Many of these disorders resemble human diseases, and the Rap1 signal with its regulators may provide rational molecular targets for controlling certain human diseases including malignancy.
Similar articles
-
Ras and Rap1: two highly related small GTPases with distinct function.Exp Cell Res. 1999 Nov 25;253(1):157-65. doi: 10.1006/excr.1999.4695. Exp Cell Res. 1999. PMID: 10579920 Review.
-
Rap1 and SPA-1 in hematologic malignancy.Trends Mol Med. 2004 Aug;10(8):401-8. doi: 10.1016/j.molmed.2004.06.004. Trends Mol Med. 2004. PMID: 15310461 Review.
-
The requirement of Ras and Rap1 for the activation of ERKs by cAMP, PACAP, and KCl in cerebellar granule cells.J Neurochem. 2007 Apr;101(2):470-82. doi: 10.1111/j.1471-4159.2006.04390.x. Epub 2007 Jan 24. J Neurochem. 2007. PMID: 17254020
-
Does Rap1 deserve a bad Rap?Trends Biochem Sci. 2003 May;28(5):267-75. doi: 10.1016/S0968-0004(03)00087-2. Trends Biochem Sci. 2003. PMID: 12765839 Review.
-
Antigen-driven T cell anergy and defective memory T cell response via deregulated Rap1 activation in SPA-1-deficient mice.Proc Natl Acad Sci U S A. 2003 Sep 16;100(19):10919-24. doi: 10.1073/pnas.1834525100. Epub 2003 Sep 4. Proc Natl Acad Sci U S A. 2003. PMID: 12958214 Free PMC article.
Cited by
-
Dok-4 is a novel negative regulator of T cell activation.J Immunol. 2009 Jun 15;182(12):7681-9. doi: 10.4049/jimmunol.0802203. J Immunol. 2009. PMID: 19494292 Free PMC article.
-
The Role of Ras-Associated Protein 1 (Rap1) in Cancer: Bad Actor or Good Player?Biomedicines. 2020 Sep 7;8(9):334. doi: 10.3390/biomedicines8090334. Biomedicines. 2020. PMID: 32906721 Free PMC article. Review.
-
P300/CBP inhibition sensitizes mantle cell lymphoma to PI3Kδ inhibitor idelalisib.Acta Pharmacol Sin. 2022 Feb;43(2):457-469. doi: 10.1038/s41401-021-00643-2. Epub 2021 Apr 13. Acta Pharmacol Sin. 2022. PMID: 33850273 Free PMC article.
-
Tumor DNA methylation profiles correlate with response to anti-PD-1 immune checkpoint inhibitor monotherapy in sarcoma patients.J Immunother Cancer. 2021 Mar;9(3):e001458. doi: 10.1136/jitc-2020-001458. J Immunother Cancer. 2021. PMID: 33762319 Free PMC article.
-
Rap1A, Rap1B, and β-Adrenergic Signaling in Autologous HCT: A Randomized Controlled Trial of Propranolol.Yale J Biol Med. 2022 Mar 31;95(1):45-56. eCollection 2022 Mar. Yale J Biol Med. 2022. PMID: 35370486 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical